Clinical Trial Information

Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (Nivo-MR2) Induction Followed by Lenalidomide and Nivolumab Maintenance in Primary CNS Lymphoma

Protocol Number: A051901
Status: Open
Age Group: Adult
Treatment Type: Treatment
Phase: I
NCT ID: NCT04609046

Scope Information

Scope:: National
Disease Site(s):: Non-Hodgkin Lymphoma